Investigating a natural treatment for severe stroke with reduced consciousness
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a natural substance (called BCS) to see if it can help people who have had a severe stroke and are not fully awake. It looks at whether giving BCS soon after a stroke can improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain).
- Your level of consciousness is reduced (score between 3 and 12 on a standard awareness test).
- You can start treatment within 24 hours of the stroke, or within 24 hours of when you were last seen well.
- You were able to live independently before the stroke (no significant disability).
- A brain scan has ruled out bleeding or other non-stroke causes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether Cerebrolysin can improve recovery in people who remain in a vegetative or minimally conscious state more than 4 weeks after a bleeding stroke. It also tracks safety, to make sure the treatment is not causing harmful side effects.
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
This study tests an investigational traditional Chinese medicine called Calculus Bovis Sativus (CBS) for people who have had an ischemic stroke or have small vessel disease in the brain. It aims to see if CBS can help recovery and is safe to use.
This trial tests whether BXOS110, an experimental injection, can help people recover better after an acute ischemic stroke (a stroke caused by a blood clot) when given within 3 hours of symptom onset. The study compares BXOS110 to a placebo to see if it reduces disability and improves recovery.
This trial tests whether Cerebrolysin (a medication given through an IV) can help improve recovery after a stroke when given after a successful clot-removal procedure that happened several hours after the stroke began. It is being tested in people who had a large-vessel stroke in the front of the brain and meets certain imaging criteria. The goal is to see if the drug can reduce disability and improve recovery.
This trial tests if a non-invasive brain stimulation technique called iTBS can help people recover motor function after a stroke caused by a large clot in the front part of the brain. It is for patients who had the clot removed successfully with a procedure within 24 hours of symptoms starting.
Hear when a new Acute Ischemic Stroke AIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.